InsiderTrades

Form 4 for ZBH Zimmer Biomet

Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0001062993-25-002917 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-19 2025-02-18 ZBH Yi Sang Group Pres, Asia Pacific M - OptEx $0.00 +11.1K 16.7K +201% $0
D 2025-02-19 2025-02-14 ZBH Yi Sang Group Pres, Asia Pacific A - Grant $0.00 +11.1K 11.1K New $0
D 2025-02-19 2025-02-18 ZBH Yi Sang Group Pres, Asia Pacific M - OptEx $0.00 -11.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-18 M A 11,138 $0.00 16,676 D — — (F1) Includes 216 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 18, 2025.
2 Derivative Restricted Stock Units 2025-02-14 A A 11,138 $0.00 11,138 D — · 2025-02-18 to 2025-02-18 11,138 Common Stock (F3) On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 11,138 RSUs, which vested on February 18, 2025 (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company").
3 Derivative Restricted Stock Units 2025-02-18 M D 11,138 $0.00 0 D — · 2025-02-18 to 2025-02-18 11,138 Common Stock (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company").